SARAH STUART: Open Payments
NPI 1063918563 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$613 in 32 payments from 8 companies in 2025. Trend: 2023 $92 · 2024 $317 · 2025 $613
Food & beverage: $613
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $162 |
| Janssen Pharmaceuticals, Inc | 5 | $107 |
| Alkermes, Inc. | 5 | $103 |
| ABBVIE INC. | 3 | $59 |
| Teva Pharmaceuticals USA, Inc. | 3 | $55 |
| Neurocrine BioSciences, Inc. | 2 | $54 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Lundbeck LLC | 2 | $36 |
Products named: ABILIFY ASIMTUFII, ARISTADA, SPRAVATO, REXULTI, VRAYLAR, UZEDY, INGREZZA, COBENFY.
Industry payments across LA — which companies pay providers there.
